Table 3.
Association of dialysis duration with HDL-associated proteins
| Protein and Model | Ratio of Protein Concentrations per Month Longer on Chronic Dialysisa | 95% Confidence Interval | P Value |
|---|---|---|---|
| Serum Amyloid A2 | |||
| Unadjusted | 1.01 | 0.89 to 1.13 | |
| Model 2b | 1.03 | 0.91 to 1.16 | 0.61 |
| Serum Amyloid A1 | |||
| Unadjusted | 1.05 | 0.97 to 1.14 | |
| Model 2 | 1.05 | 0.97 to 1.15 | 0.19 |
| Hemoglobin-β | |||
| Unadjusted | 0.98 | 0.90 to 1.06 | |
| Model 2 | 0.97 | 0.90 to 1.06 | 0.61 |
| Haptoglobin-Related Protein | |||
| Unadjusted | 1.02 | 0.97 to 1.07 | |
| Model 2 | 1.00 | 0.96 to 1.06 | 0.75 |
| Cholesterol Ester Transfer Protein | |||
| Unadjusted | 0.99 | 0.96 to 1.03 | |
| Model 2 | 0.99 | 0.96 to 1.03 | 0.79 |
| Phospholipid Transfer Protein | |||
| Unadjusted | 1.01 | 0.97 to 1.04 | |
| Model 2 | 1.00 | 0.97 to 1.04 | 0.84 |
| Apolipoprotein E | |||
| Unadjusted | 1.00 | 0.97 to 1.03 | |
| Model 2 | 1.00 | 0.97 to 1.03 | 1.03 |
| Serum Amyloid A4 | |||
| Unadjusted | 1.00 | 0.98 to 1.03 | |
| Model 2 | 1.00 | 0.98 to 1.03 | 0.53 |
a
Ratio of geometric means.
b
Model 2 was adjusted for age, race (black versus nonblack), sex, diabetes, body mass index, prevalent cardiovascular disease, smoking, statin use, and serum concentrations of total cholesterol, HDL cholesterol, and triglycerides.